Our Mission

To make prescription drugs more affordable for all Americans. CSRxP advocates for bipartisan solutions that hold pharmaceutical companies accountable for out-of-control drug prices and provide more affordable choices for patients. We believe in market-based reforms that address the underlying causes of high drug prices in the U.S. through increased transparency, competition, and value.

Learn More

THEY SAID IT!: LAWMAKERS ROAST BIG PHARMA’S PATENT ABUSE, CALL FOR ACTION ON BIPARTISAN SOLUTIONS TO HOLD THE PHARMACEUTICAL INDUSTRY ACCOUNTABLE

Senate Judiciary Committee Puts Spotlight on Big Pharma’s Anti-Competitive Tactics that Extend Monopolies and Keep Drug Prices High On Tuesday, the U.S.

05-22-2024 Read More

DOSE OF REALITY: BIG PHARMA’S PATENT ABUSE BLOCKS COMPETITION IN THE PRESCRIPTION DRUG MARKET, KEEPS DRUG PRICES HIGH

Senate Hearing Offers Opportunity to Highlight Market-Based Solutions to Hold Big Pharma Accountable for Anti-Competitive Tactics That Cost Patients and Taxpayers Billions of Dollars The U.S. Senate

05-21-2024 Read More

DOSE OF REALITY: STUDY FINDS NEARLY THREE-QUARTERS OF BIG PHARMA’S PATENTS ON TOP-SELLING DRUGS FILED AFTER FDA APPROVAL

Analysis Showcases Egregious Scale of Big Pharma’s Patent Thickets on Blockbuster Products, Including Nearly 1,500 Patent Applications on Just Ten Drugs A new study, published in JAMA Network,

05-16-2024 Read More

View All

The Crisis

Drug prices are out-of-control. At a time when one-in-four Americans cannot afford their medication, Big Pharma is posting record profits – doubling down on monopolistic tactics to game America’s patent system, prevent generic and biosimilar competition and patient choice and pad their bottom lines.

No patient should ever have to choose between paying for their daily needs or taking the medicine they need to live. Every person deserves access to the medications they need at a price they can afford, especially those who can least afford them.

 

Learn More

Solutions

Americans deserve choice and control over their health. We must all work together to promote competition and increase access to high-quality, affordable treatments and cures for patients. It’s time for real solutions that can deliver more choices, more competition, and lower drug prices by addressing the root causes of price gouging:

Affordability: Too often patients experience the unfortunate and unfair choice between purchasing the medications they need to be well and paying for other necessities. Patients should never be presented with such a choice – especially today with so many people across the U.S. experiencing significant health and economic hardship due to the COVID-19 pandemic. Measures must be taken to improve prescription drug affordability for patients and taxpayers alike, especially while the nation continues to battle the COVID-19 pandemic and everyone across the U.S. will need access to acceptably-priced and affordable virus countermeasures.

Transparency: Patients deserve open and honest drug pricing – clear and transparent information about the true costs of treatment, how manufacturers set prices and the actual cost of bringing drugs to market, particularly for high-cost drugs. Improving pricing transparency will enable patients to become actively involved in their healthcare decision-making and put pressure on Big Pharma to lower the prices of their excessively costly drugs.

Competition: Pharmaceutical companies today abuse the patent system to prevent more affordable drugs from disrupting their monopolies over the drug marketplace. Bringing more competition to the prescription drug market will give consumers more choices and more control – resulting in lower prices and improved access.

Value: Patients deserve reliable information regarding whether a drug’s “therapeutic outcome” – or its health benefit – is in line with its price. This information is critical to moving America’s prescription drug market toward a system that empowers doctors and patients to choose medications based on the value they provide – not the “value” set by drug manufacturers.

Learn More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.

Who we are

The Campaign for Sustainable Rx Pricing (CSRxP) is a broad-based coalition of leaders – physicians, nurses, hospitals, consumers, health plans, PBMs, pharmacists, and businesses – promoting bipartisan, market-based solutions to lower drug prices in America.

Keep the Conversation Going

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

Almost three-quarters of patent applications filed by #BigPharma on their best selling products came after initial FDA approval. Big Pharma abuses the patent system to extend monopolies and keep prices high.

Learn more:

www.csrxp.org/dose-of-reality-study-finds-nearly-three-quarters-of-big-pharmas-patents-on-top-sel...
... See MoreSee Less

23 hours ago

🚨 A new Forbes piece takes a deep dive into one of #BigPharma’s most common patent abuse tactics: Product hopping.

Learn more about this anti-competitive tactic and solutions to hold Big Pharma accountable for gaming the system to extend monopolies:

www.csrxp.org/dose-of-reality-forbes-how-big-pharma-stifles-competition-with-product-hopping/?utm...
... See MoreSee Less

2 days ago

Lawmakers from both sides of the aisle called for action to hold #BigPharma accountable for egregious patent abuse during a Senate Judiciary Committee hearing this week. See what Ranking Member U.S. Senator Lindsey Graham had to say:

www.csrxp.org/they-said-it-lawmakers-roast-big-pharmas-patent-abuse-call-for-action-on-bipartisan...
... See MoreSee Less

3 days ago